drugset
drugset / Trial / NCT04600089

Ketamine in Patients Undergoing TEVAR Procedures Receiving NCI

NCT04600089 ↗

Phase 2 Recruiting 30 enrolled Sam Tyagi
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The objective of this study is to identify the opioid-sparing effects, and pain-reduction potential of low dose, sub-dissociative ketamine on patients undergoing thoracic endovascular aortic repair (TEVAR) procedures receiving naloxone continuous infusion (NCI).

Timeline

Start
2020-12-08
Primary completion
2027-08
Completion
2027-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 0.2 mg/kg —

Indications

aortic aneurysm